Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is
increasing in prevalence. HF health expenditures are considerable and will increase …

Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

Objectives: This study aimed to determine temporal trends in the incidence of and mortality
associated with heart failure (HF) and its subtypes (heart failure with reduced ejection …

Importance Adding a sodium-glucose cotransporter-2 inhibitor (SGLT2-I) to standard-of-care
treatment in patients with heart failure with preserved ejection fraction (HFpEF) reduces the …

Aims Congestion is a central feature of acute heart failure (HF) and its assessment is
important for clinical decisions (eg tailoring decongestive treatments). It remains uncertain …

Heart failure (HF) is the most common discharge diagnosis across the United States, and
these patients are particularly vulnerable to readmissions, increasing attention to potential …

Chronic heart failure (CHF) is frequently associated with the involuntary loss of body weight
and muscle wasting, which can determine the course of the disease and its prognosis. While …

Heart failure (HF) represents a global pandemic health problem with a high impact on health-
care costs, affecting about 26 million adults worldwide. The overall HF prevalence and …

Aims The aim of this study was to elucidate the clinical characteristics, including frailty status,
of patients with heart failure with preserved ejection fraction (HFpEF) in comparison with …

Diabetes mellitus (DM) is a major cause of heart failure in the Western world, either
secondary to coronary artery disease or from a distinct entity known as “diabetic …